Literature DB >> 2987464

Matrix vesicle enzymes in human osteoarthritis.

T A Einhorn, S L Gordon, S A Siegel, C F Hummel, M J Avitable, R P Carty.   

Abstract

The enzymatic activities and in vitro calcification properties of matrix vesicle fractions isolated from normal and osteoarthritic (OA) human articular cartilage were compared to determine the essential conditions for calcification in these tissues. Four groups of human cartilage were examined, I, normal articular cartilage from aged, nonOA joints; II, discolored or fibrillated cartilage from OA joints; III, osteophytic cartilage from OA joints; IV, loose body cartilage from OA joints. Fetal bovine growth plate cartilage was also studied. Both ATP- and 5'-AMP-dependent in vitro matrix vesicle calcification occurs in all cartilage groups examined and, for human articular cartilage, these activities increase progressively from Groups I to II to III. Calcification does not occur in the absence of either phosphate or pyrophosphate. Alkaline phosphatase, 5'-AMPase, and ATP:pyrophosphohydrolase activities are increased in Groups III and IV cartilage compared with Group I and are detected at high levels in fetal bovine growth plate cartilage. Pyrophosphatase activity occurs in only those cartilage groups juxtaposed to areas of new bone formation (osteophytic, loose body, and bovine growth plate). These results suggest that OA, growth plate, and even normal articular cartilage all have the potential to undergo calcification as long as both phosphate and pyrophosphate ions can be generated at sufficiently high levels. However, the capacity for cartilage to deposit hydroxyapatite, as it does during bone formation, may depend on the presence of pyrophosphatase activity.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2987464     DOI: 10.1002/jor.1100030205

Source DB:  PubMed          Journal:  J Orthop Res        ISSN: 0736-0266            Impact factor:   3.494


  12 in total

Review 1.  Matrix vesicles and calcification.

Authors:  H Clarke Anderson
Journal:  Curr Rheumatol Rep       Date:  2003-06       Impact factor: 4.592

2.  Matrix vesicles are enriched in metalloproteinases that degrade proteoglycans.

Authors:  D D Dean; Z Schwartz; O E Muniz; R Gomez; L D Swain; D S Howell; B D Boyan
Journal:  Calcif Tissue Int       Date:  1992-04       Impact factor: 4.333

3.  Association between synovial fluid levels of inorganic pyrophosphate and short term radiographic outcome of knee osteoarthritis.

Authors:  M Doherty; C Belcher; M Regan; A Jones; J Ledingham
Journal:  Ann Rheum Dis       Date:  1996-07       Impact factor: 19.103

4.  Expression of early and late differentiation markers (proliferating cell nuclear antigen, syndecan-3, annexin VI, and alkaline phosphatase) by human osteoarthritic chondrocytes.

Authors:  D Pfander; B Swoboda; T Kirsch
Journal:  Am J Pathol       Date:  2001-11       Impact factor: 4.307

Review 5.  Extracellular vesicles in cartilage homeostasis and osteoarthritis.

Authors:  Shigeru Miyaki; Martin K Lotz
Journal:  Curr Opin Rheumatol       Date:  2018-01       Impact factor: 5.006

Review 6.  Biomineralization and matrix vesicles in biology and pathology.

Authors:  Ellis E Golub
Journal:  Semin Immunopathol       Date:  2010-12-08       Impact factor: 9.623

Review 7.  Crystal-induced inflammation and cartilage degradation.

Authors:  G M McCarthy
Journal:  Curr Rheumatol Rep       Date:  1999-12       Impact factor: 4.592

8.  Role of acute trauma in development of osteoarthritis.

Authors:  T R Oegema; J L Lewis; R C Thompson
Journal:  Agents Actions       Date:  1993-11

9.  Differential effects of parathyroid hormone on chick growth plate and articular chondrocytes.

Authors:  I D Crabb; R J O'Keefe; J E Puzas; R N Rosier
Journal:  Calcif Tissue Int       Date:  1992-01       Impact factor: 4.333

10.  Promotion of articular cartilage matrix vesicle mineralization by type I collagen.

Authors:  Brian Jubeck; Claudia Gohr; Mark Fahey; Emily Muth; Michele Matthews; Eric Mattson; Carol Hirschmugl; Ann K Rosenthal
Journal:  Arthritis Rheum       Date:  2008-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.